Clinical Trials for AVEO Pharmaceuticals

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AVEO Pharmaceuticals

Clinical Trials (4)

NCT06064877
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
PHASE3Recruiting
410 participants
Started: Jan 11, 2024 · Completed: Nov 30, 2027
2 conditions1 sponsor110 locations
NCT06053658
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
PHASE2Recruiting
48 participants
Started: Jan 5, 2024 · Completed: Nov 1, 2028
1 condition2 sponsors5 locations
NCT05865535
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
PHASE1Recruiting
30 participants
Started: Jun 13, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor12 locations
NCT04987203
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
PHASE3Active, not recruiting
343 participants
Started: Sep 9, 2021 · Completed: Dec 30, 2025
1 condition3 sponsors139 locations